[Experimental and clinical evaluation of alpha-propyl-2-thioisonicotinamide (1321 TH)].
D005000:Ethionamide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D005000:Ethionamide